<DOC>
	<DOCNO>NCT00857441</DOCNO>
	<brief_summary>The purpose DEBIUT study assess procedural , clinical angiographic outcome : 1 . Provisional T-stenting use dilation Paclitaxel-eluting PCI-balloon ( DiorTM ) comparison dilation standard balloon prior implant Liberty Bare Metal Stent bifurcation lesion ( side branch involvement ) . 2 . Comparison result result use standard balloon prior provisional T-stenting Paclitaxel-eluting stent TaxusTM Libert√©TM .</brief_summary>
	<brief_title>Drug-eluting Balloon Bifurcations Trial</brief_title>
	<detailed_description />
	<mesh_term>Coronary Artery Disease</mesh_term>
	<mesh_term>Myocardial Ischemia</mesh_term>
	<mesh_term>Coronary Disease</mesh_term>
	<mesh_term>Atherosclerosis</mesh_term>
	<mesh_term>Angina Pectoris</mesh_term>
	<mesh_term>Angina , Unstable</mesh_term>
	<mesh_term>Angina , Stable</mesh_term>
	<criteria>Stable angina pectoris ( CCS class 1,2,3,4 ) unstable angina document ischemia silent ischemia Patients eligible coronary revascularisation The target bifurcation lesion major native coronary artery ( &gt; 2.5mm ) stenosis &gt; 50 % ( visual assessment ) locate side branch ( &gt; 2mm ) Patient must acceptable CABG De novo lesion The main vessel lesion cover one stent ( 32mm ) Only one target lesion include study : lesion different vessel successfully treat treatment target lesion ( residual stenosis &lt; 30 % , stent well deploy , residual dissection , normal TIMI flow , chest pain , ECG unchanged compare preprocedural ECG ) Signed patient informed consent Patient unable give inform consent Patients previous PCI target vessel Patients stent restenosis target lesion Left ventricular ejection fraction 30 % Patients leave main disease Severe calcification undilatable lesion balloon predilatation History bleed diathesis Untreated significant lesion great 50 % diameter stenosis remain proximal distal target intervention . Patient suffer stroke TIA within past 3 month Life expectancy &lt; 1 year Any major surgery plan require next 6 month Acute Myocardial Infarction Only one target lesion include study Allergy contrast and/or require antiplatelet medication Patients unwilling return followup 6 month</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>July 2015</verification_date>
</DOC>